Leading Geneticist Takes The Helm At Qatar Biobank

Publication Date:
15/07/13 8:00 AM

Qatar Biobank has appointed a leading industry expert, Dr Hadi Abderrahim as its Managing Director to continue the drive for research into medical conditions that prevail in Qatar.

Dr Abderrahim’s commendable career includes founding GBM Consulting, a biotech strategy firm, consulting on clinical trials and business development. As Head of Genetics and Biomarkers at renowned Merck Serono, the $5 billion plus, revenue-earning pharmaceutical company based in Geneva, Dr Abderrahim oversaw a team of 40 and established a central Biobank based in Italy.

He obtained his M.D. speciality in Human Genetics from the prestigious Hopital Necker, Paris, and he has a PhD in Human Genetics and an executive MBA from HEC in Paris.

Dr Abderrahim’s PhD on ‘Cloning and characterization of the human MHC complex’, was advised on by Jean Dausset, a Nobel laureate.

Dr Abderrahim said, “Qatar’s robust efforts in the realm of advancing medical research are evident and offer an unparalleled opportunity to give Qatar’s population stronger chances of avoiding serious illnesses. My vision is to continue the great work of our team to raise Qatar’s profile as a biomedical research hub and ultimately position Qatar as a leader in the field.”



You are being invited to take part in Qatar Biobank, Qatar’s long-term medical health initiative for Qatar’s population. To help you decide whether to contribute, here is some information on Qatar Biobank and what taking part involves.


Health Supplement-The Edge.jpg

Qatar Biobank will make it possible for scientists to conduct research to address some of the greatest health challenges facing Qatar and the region, including cardiovascular disease, obesity, diabetes, and cancer.


Qatar Foundation Ministry of Public Health
Hamad Medical Corporation


Quality Management Information Security Management